Format

Send to

Choose Destination
Obstet Gynecol Clin North Am. 2013 Jun;40(2):377-90. doi: 10.1016/j.ogc.2013.03.002. Epub 2013 Apr 6.

Human papillomavirus testing in cervical cancer screening.

Author information

1
Global Cancer Initiative, 100 Radcliffe, Dr Chestertown, MD 21620, USA. castle.philip@gmail.com

Abstract

Human papillomavirus (HPV) testing is more reliable and sensitive but less specific than Papanicolaou (Pap) testing/cervical cytology for the detection of cervical precancer and cancer. HPV-negative women are at lower risk of cervical cancer than Pap-negative women. In high-resource settings, HPV testing can be used to make cervical cancer prevention programs more efficient by focusing clinical attention on women who have HPV. In lower-resource settings, where Pap testing has not been sustained or widespread, new, lower-cost HPV tests may make cervical cancer screening feasible.

PMID:
23732037
DOI:
10.1016/j.ogc.2013.03.002
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center